Page results
-
This information page aims to answer some of the questions you may have about receiving chimeric antigen receptor (CAR) T-cell therapy at University College London Hospitals NHS Foundation Trust (UCLH).
-
This page has information on how to treat iron overload with Desferrioxamine. It has information on how the medicine is delivered and how you can do it at home.
-
This information explains what blood clots are and how we can help to prevent them.
-
The UCLH post-COVID service is the lead provider for North Central London (NCL) and works with borough based services to provide support and assessment for patients with ongoing symptoms (long covid) following COVID-19 infection.
-
Olfactory smell clinic for people who have lost their sense of smell and taste after having COVID-19.
-
We provide a comprehensive service from early diagnosis to advanced treatments for severe COPD. We have a strong multidisciplinary team (MDT) including doctors, specialist nurses, physiotherapists, physiologists and psychologists, which enables us to provide holistic, personalised care to each of our patients.
-
The Haemophagocytic Lymphohistiocytosis (HLH) Service was established at UCLH to offer high-quality care for people suspected of having HLH.
-
Hypopharyngeal cancer is a rare type of cancer that affects the inlet to the oesophagus (gullet).
-
Professor Hough is a consultant heamatologist at UCLH. She has specialist expertise in the management of acute lymphoblastic leukaemia in teenagers and young adults, and the use of umbilical cord blood as an alternative source of haemopoietic stem cells.
-
Our cancer team monitors all urgent, two-week wait, suspected cancer referrals from GPs. All appointments are carefully and systematically monitored to ensure a speedy and efficient patient journey from diagnosis to treatment or discharge.
File results
-
FOI/2024/0372 - Contact details of e-learning department
-
FOI/2024/0373 - Allogeneic stem cell transplants/ ECP (ExtraCorporeal Photopheresis) service
-
FOI/2024/0376 - Advice provided on topical medication for eczema patients
-
FOI/2024/0381 - Proton Beam Therapy Centre material use, architectural technology and performance
-
FOI/2024/0385 - Immunoglobulin vials (by brands) distributed to patients
-
FOI/2024/0386 - Stonewall funding for 2022/23-2023/24
-
FOI/2024/0391 - Hospital admissions due to psychedelics consumption
-
FOI/2024/0404 - Senior HR/ Workforce staff contact details
-
FOI/2024/0409 - Number of A&E attendees with mental health complaints from 2022 to 2024
-
FOI/2024/0415 - Biologic and targeted medications within dermatology medicine